ClearTrial Awarded Best of Show at Bio-IT World Conference & Expo 2012

Demonstrates the significant business value ClearTrial software brings to life sciences companies

CHICAGO--(BUSINESS WIRE)-- ClearTrial (http://www.cleartrial.com) announced today that the company’s cloud-based Clinical Trial Operations software, ClearTrial 4.5, was awarded Best of Show in the Clinical Trials & Research category at the 11th Annual Bio-IT World Conference & Expo. Attended by more than 2,000 life sciences, pharmaceutical, clinical, healthcare, and IT professionals from 30 countries, the conference provides the leading venue to share information and discuss enabling technologies that are driving biomedical research and the drug development process.

The Bio-IT World Best of Show Award “distinguishes and highlights products from the competition,” according to Bio-IT World. Judged by a team of leading industry experts and Bio-IT World editors, the Best of Show program identifies exceptional innovation in technologies used by life science professionals today. The winners were judged based on the products’ technical merit, functionality, innovation, and in-person presentations to the judges at the show.

At the conference, ClearTrial demonstrated to the judges how its software makes the planning, forecasting, and tracking of clinical project and financial performance faster and more accurate – a critical enabler of business value for life sciences companies in today’s difficult operating environment. The company also showed how ClearTrial 4.5:

  • Streamlines the entire clinical development process from planning to payment
  • Improves and speeds the budget planning and forecasting process
  • Provides transparency into trial performance and timelines for improved collaboration, decision-making, and R&D capital management

“It is a privilege to receive the Bio-IT World Best of Show award, and ClearTrial would like to thank the judges and conference staff for this honor,” stated Andrew Grygiel, Chief Marketing Officer for ClearTrial. “This award is really a testament to the passion, dedication, and hard work of everyone at ClearTrial who has made our software a leader in the industry, helping life sciences companies bring life-improving treatments to market more quickly and cost-effectively.”

About ClearTrial®

ClearTrial is the leading provider of Clinical Trial Operations (CTO) software, linking clinical planning, forecasting, and tracking of operational and financial performance in a single, integrated system. ClearTrial’s award-winning software helps life sciences companies streamline their clinical operations from Plan to Payment™ without sacrificing quality of results, providing executives and functional leaders in clinical operations, resource planning, finance, outsourcing, and project management with a common platform that promotes speed, accuracy, and consistency throughout the organization. For more information visit http://www.cleartrial.com.

ClearTrial® and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Oracle and Java are registered trademarks of Oracle and/or its affiliates. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners.

Connect with ClearTrial:

Twitter

LinkedIn

YouTube



CONTACT:

ClearTrial
Mike Lange
+1 312.460.3015
[email protected]

KEYWORDS:   United States  North America  Illinois  Massachusetts

INDUSTRY KEYWORDS:   Technology  Data Management  Software  Other Technology  Health  Biotechnology  Clinical Trials  Other Science  Science

MEDIA:

Logo
 Logo

Suggested Articles

Startup insurer Oscar Health is set to launch its first Medicare Advantage plans in New York City and Houston for the 2020 plan year.

Clinical Pathology Laboratories, based in Austin, Texas, says 2.2 million patients may have had their personal information compromised.

A new study finds merely providing access to technology has not helped to close the digital divide for African American and older patients.